Literature DB >> 8938048

High expression of plasmid-encoded tetracycline resistance gene in E. coli causes a decrease in membrane-bound ATPase activity.

M S Valenzuela1, K A Siddiqui, B L Sarkar.   

Abstract

Expression of the plasmid pBR322-encoded tetracycline-resistant gene (tet) is known to cause other pleiotropic effects in addition to mediating the efflux of tetracycline from bacterial host cells. We have recently reported that expression of the tet gene in plasmid pKH47, a high-copy-number derivative of pBR322, causes growth inhibition of Escherichia coli cells harboring this plasmid. In this paper we report that reduced membrane-bound ATPase activity is found in E. coli cells containing plasmid pKH47. This effect is dependent on the presence of an intact tet gene and reduces the ability of the cells to grow in a minimum medium containing succinate as the sole carbon source. The same effect is more dramatically observed in cells containing an unrelated plasmid in which tet gene expression is under the control of the tac promoter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938048     DOI: 10.1006/plas.1996.0027

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  3 in total

1.  Reduction of acid tolerance by tetracycline in Escherichia coli expressing tetA(C) is reversed by cations.

Authors:  Kai F Hung; Jeffrey J Byrd; Jeffrey L Bose; Charles W Kaspar
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

2.  Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis.

Authors:  Anna C Jacobs; Indriati Hood; Kelli L Boyd; Patrick D Olson; John M Morrison; Steven Carson; Khalid Sayood; Peter C Iwen; Eric P Skaar; Paul M Dunman
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

Review 3.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.